Table of Content


Introduction
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Overview
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Therapeutics Development
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Therapeutics Assessment
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Companies Involved in Therapeutics Development
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Drug Profiles
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Dormant Projects
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Discontinued Products
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Human Immunodeficiency Virus (HIV) Infections (AIDS), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Human Immunodeficiency Virus (HIV) Infections (AIDS), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Number of Products by Stage and Molecule Type, H2 2020 (Contd..1), H2 2020
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline by 2A Pharma AB, H2 2020
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline by AbbVie Inc, H2 2020
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Dormant Projects, H2 2020
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Discontinued Products, H2 2020